Vogelmeier CF - Search Results

1

In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations.

Worth H, Buhl R, Criée CP, Kardos P, Gückel E, Vogelmeier CF. Worth H, et al. Among authors: vogelmeier cf. Respir Res. 2023 Jan 5;24(1):2. doi: 10.1186/s12931-023-02311-x. Respir Res. 2023. PMID: 36604646 Free PMC article.

2

[Pathogenesis of idiopathic pulmonary fibrosis].

Buhl R, Meier-Sydow J, Vogelmeier C. Buhl R, et al. Immun Infekt. 1995 Jun;23(3):92-6. Immun Infekt. 1995. PMID: 7615308 Review. German.

3

[Therapy of lung diseases with antiproteases].

Vogelmeier C, Buhl R. Vogelmeier C, et al. Pneumologie. 1994 Feb;48(2):57-62. Pneumologie. 1994. PMID: 7910401 Review. German.

4

[Therapy of lung diseases with anti-oxidants].

Buhl R, Vogelmeier C. Buhl R, et al. Pneumologie. 1994 Feb;48(2):50-6. Pneumologie. 1994. PMID: 8183872 Review. German.

5

Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.

Vogelmeier C, Gillissen A, Buhl R. Vogelmeier C, et al. Chest. 1996 Dec;110(6 Suppl):261S-266S. doi: 10.1378/chest.110.6_supplement.261s. Chest. 1996. PMID: 8989162 Review.

6

Oxidant-protease interaction in the lung. Prospects for antioxidant therapy.

Buhl R, Meyer A, Vogelmeier C. Buhl R, et al. Chest. 1996 Dec;110(6 Suppl):267S-272S. doi: 10.1378/chest.110.6_supplement.267s. Chest. 1996. PMID: 8989163 Review.

7

Comparative loss of activity of recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor caused by different forms of oxidative stress.

Vogelmeier C, Biedermann T, Maier K, Mazur G, Behr J, Krombach F, Buhl R. Vogelmeier C, et al. Eur Respir J. 1997 Sep;10(9):2114-9. doi: 10.1183/09031936.97.10092114. Eur Respir J. 1997. PMID: 9311513 Free article.

8

[Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study].

Buhl R, Kardos P, Magnussen H, Matthys H, Sauer R, Schauer P, Vogelmeier C, Wettengel R, Worth H, Menz G. Buhl R, et al. Pneumologie. 1999 Apr;53(4):210-2. Pneumologie. 1999. PMID: 10409864 Review. German. No abstract available.

9

[Inhalable corticosteroids in long-term COPD treatment. Opinions of an expert panel].

Gillissen A, Barczok M, Buhl R, Kardos P, Magnussen H, Matthys H, Rabe KF, Rothe T, Russi EW, Schauer J, Schmitz M, Vogelmeier C, Wettengel R, Worth H, Menz G. Gillissen A, et al. Pneumologie. 2000 Jun;54(6):256-62. doi: 10.1055/s-2000-3826. Pneumologie. 2000. PMID: 10934897 Review. German. No abstract available.

10

[Solid combination of budesonide and formoterol in the treatment of bronchial asthma].

Gillissen A, Buhl R, Magnussen H, Menz G, Rabe K, Vogelmeier C, Worth H. Gillissen A, et al. Pneumologie. 2001 Mar;55(3):159-62. doi: 10.1055/s-2001-12436. Pneumologie. 2001. PMID: 11293852 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters